Blair William & CO Madrigal Pharmaceuticals, Inc. Transaction History

Blair William & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $213,232 - $484,965	-2,250 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$207.3 - $300.31 $719,331 - $1.04 Million	-3,470 Reduced 60.66%	2,250 $482,000
Q2 2018 Aug 13, 2018	BUY	$101.55 - $313.9 $268,193 - $829,009	2,641 Added 85.77%	5,720 $1.6 Million
Q1 2018 May 15, 2018	BUY	$93.35 - $149.04 $287,424 - $458,894	3,079 New	3,079 $360,000

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.